|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
ES2234451T1
(es)
|
2001-11-14 |
2005-07-01 |
Teva Pharmaceutical Industries Ltd. |
Formas cristalinas y amorfas de losartan potasio y procedimiento para su preparacion.
|
|
AU2005266090A1
(en)
|
2004-07-23 |
2006-02-02 |
Pfizer Inc. |
Pyridine derivatives
|
|
WO2008060789A2
(en)
|
2006-10-12 |
2008-05-22 |
Xenon Pharmaceuticals Inc. |
Use of spiro-oxindole compounds as therapeutic agents
|
|
CA2684105C
(en)
|
2007-05-03 |
2011-09-06 |
Pfizer Limited |
Pyridine derivatives
|
|
MX2011006904A
(es)
|
2008-12-26 |
2011-07-20 |
Dainippon Sumitomo Pharma Co |
Compuesto heterociclico biciclico novedoso.
|
|
CA2760946C
(en)
|
2009-05-07 |
2019-06-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for studying, imaging, and treating pain
|
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
|
WO2011026240A1
(en)
|
2009-09-04 |
2011-03-10 |
Zalicus Pharmaceuticals Ltd. |
Oxopiperazine derivatives for the treatment of pain and epilepsy
|
|
US8598164B2
(en)
|
2010-05-06 |
2013-12-03 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
|
|
KR101923367B1
(ko)
|
2011-02-02 |
2018-12-04 |
버텍스 파마슈티칼스 인코포레이티드 |
이온 채널의 조절제로서의 피롤로피라진―스피로사이클릭 피페리딘 아미드
|
|
MX2013009393A
(es)
|
2011-02-18 |
2013-08-29 |
Vertex Pharma |
Piperidinamidas cromano-espirociclicas como moduladores de canales de iones.
|
|
CA2828456C
(en)
|
2011-03-03 |
2021-05-04 |
Zalicus Pharmaceuticals Ltd. |
N-benzl-amino-carboxamide inhibitors of the sodium channel
|
|
CN103517910B
(zh)
|
2011-03-14 |
2016-12-14 |
沃泰克斯药物股份有限公司 |
作为离子通道调节剂的吗啉-螺环哌啶酰胺
|
|
CA2850925C
(en)
|
2011-10-26 |
2017-01-10 |
Pfizer Limited |
(4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators
|
|
US9012443B2
(en)
|
2011-12-07 |
2015-04-21 |
Amgen Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
|
NZ627259A
(en)
|
2012-01-16 |
2016-12-23 |
Vertex Pharma |
Pyran-spirocyclic piperidine amides as modulators of ion channels
|
|
JP6002785B2
(ja)
|
2012-02-03 |
2016-10-05 |
ファイザー・インク |
ナトリウムチャネルモジュレーターとしてのベンゾイミダゾールおよびイミダゾピリジン誘導体
|
|
WO2013131018A1
(en)
|
2012-03-02 |
2013-09-06 |
Zalicus Pharmaceuticals Ltd. |
Biaryl inhibitors of the sodium channel
|
|
WO2013134518A1
(en)
|
2012-03-09 |
2013-09-12 |
Amgen Inc. |
Sulfamide sodium channel inhibitors
|
|
US20140211173A1
(en)
|
2013-01-30 |
2014-07-31 |
3M Innovative Properties Company |
Optical projection subsystem
|
|
CA2898653C
(en)
|
2013-01-31 |
2021-09-28 |
Vertex Pharmaceuticals Incorporated |
Amides as modulators of sodium channels
|
|
RS56015B1
(sr)
|
2013-01-31 |
2017-09-29 |
Vertex Pharma |
Piridon amidi kao modulatori natrijumovih kanala
|
|
RU2683788C2
(ru)
|
2013-01-31 |
2019-04-02 |
Вертекс Фармасьютикалз Инкорпорейтед |
Амиды хинолина и хиназолина, полезные в качестве модуляторов натриевых каналов
|
|
US9776995B2
(en)
|
2013-06-12 |
2017-10-03 |
Amgen Inc. |
Bicyclic sulfonamide compounds as sodium channel inhibitors
|
|
UA119147C2
(uk)
|
2013-07-19 |
2019-05-10 |
Вертекс Фармасьютікалз Інкорпорейтед |
Сульфонаміди як модулятори натрієвих каналів
|
|
CA2931550C
(en)
|
2013-12-13 |
2023-09-26 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
|
WO2015157559A2
(en)
|
2014-04-09 |
2015-10-15 |
Siteone Therapeutics, Inc. |
10',11'-modified saxitoxins for the treatment of pain
|
|
EA032928B1
(ru)
|
2015-03-02 |
2019-08-30 |
Эмджен Инк. |
Бициклические кетосульфонамидные соединения
|
|
ES2895155T3
(es)
|
2015-09-30 |
2022-02-17 |
Siteone Therapeutics Inc |
Saxitoxinas modificadas en 11,13 para el tratamiento del dolor
|
|
US11279706B2
(en)
|
2017-03-29 |
2022-03-22 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
|
CN110831945B
(zh)
|
2017-03-29 |
2023-08-08 |
赛特温治疗公司 |
用于治疗疼痛的11,13-修饰的石房蛤毒素类化合物
|
|
EP3625214B1
(en)
|
2017-05-16 |
2022-07-06 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
|
AU2018300150A1
(en)
|
2017-07-11 |
2020-01-30 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
AU2019302534B2
(en)
|
2018-07-09 |
2024-10-03 |
Lieber Institute, Inc. |
Pyridazine compounds for inhibiting NaV1.8
|
|
CA3105657A1
(en)
|
2018-07-09 |
2020-01-16 |
Lieber Institute, Inc. |
Pyridine carboxamide compounds for inhibiting nav1.8
|
|
EP3860714B1
(en)
|
2018-10-03 |
2023-09-06 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
|
US12344595B2
(en)
|
2018-11-02 |
2025-07-01 |
Merck Sharp & Dohme Llc |
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors
|
|
JP7288051B2
(ja)
*
|
2018-11-02 |
2023-06-06 |
メルク・シャープ・アンド・ドーム・エルエルシー |
Ｎａｖ１．８阻害薬としての２－アミノ－Ｎ－ヘテロアリール－ニコチンアミド類
|
|
EP3891157A4
(en)
|
2018-12-05 |
2022-08-31 |
Merck Sharp & Dohme Corp. |
4-AMINO- OR 4-ALKOXY-SUBSTITUTED ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATE SODIUM CHANNELS
|
|
US20220073471A1
(en)
|
2019-01-04 |
2022-03-10 |
Jiangsu Hengrui Medicine Co., Ltd. |
6-oxo-1,6-dihydropyridazine derivative, preparation method therefor and medical use thereof
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US12440481B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
TW202043200A
(zh)
|
2019-01-25 |
2020-12-01 |
大陸商江蘇恆瑞醫藥股份有限公司 |
２－側氧基－１，２－二氫吡啶類衍生物、其製備方法及其在醫藥上的應用
|
|
MX2021015605A
(es)
|
2019-06-27 |
2022-02-16 |
Glaxosmithkline Ip Dev Ltd |
Compuestos 2,3-dihidroquinazolin como inhibidores nav1.8.
|
|
CN112300051A
(zh)
|
2019-07-31 |
2021-02-02 |
明慧医药（上海）有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
CN112300069A
(zh)
|
2019-07-31 |
2021-02-02 |
明慧医药（上海）有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
WO2021032074A1
(zh)
|
2019-08-19 |
2021-02-25 |
江苏恒瑞医药股份有限公司 |
苯甲酰胺稠芳环类衍生物、其制备方法及其在医药上的应用
|
|
CN112390745B
(zh)
|
2019-08-19 |
2022-10-21 |
江苏恒瑞医药股份有限公司 |
吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用
|
|
CN112441969A
(zh)
|
2019-08-30 |
2021-03-05 |
明慧医药（上海）有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
BR112022004495A8
(pt)
|
2019-09-12 |
2023-04-18 |
Jiangxi Jemincare Group Co Ltd |
Compostos oxinitreto de piridina, composição farmacêutica compreendendo os mesmos e usos dos mesmos
|
|
BR112022010924A2
(pt)
|
2019-12-06 |
2022-09-06 |
Vertex Pharma |
Tetra-hidrofuranos substituídos como moduladores de canais de sódio
|
|
CN111217776A
(zh)
|
2020-01-19 |
2020-06-02 |
中国人民解放军军事科学院军事医学研究院 |
含苯并杂环结构的酰胺衍生物、组合物和应用
|
|
CA3183948A1
(en)
|
2020-06-10 |
2021-12-16 |
Amgen Inc. |
Heteroalkyl dihydroquinoline sulfonamide compounds
|
|
JP2021195367A
(ja)
|
2020-06-10 |
2021-12-27 |
アムジエン・インコーポレーテツド |
シクロプロピルジヒドロキノリンスルホンアミド化合物
|
|
JP7739051B2
(ja)
|
2020-06-10 |
2025-09-16 |
アムジエン・インコーポレーテツド |
シクロブチルジヒドロキノリンスルホンアミド化合物
|
|
US11802122B2
(en)
|
2020-06-17 |
2023-10-31 |
Merck Sharp & Dohme Llc |
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors
|
|
US12516046B2
(en)
|
2020-06-17 |
2026-01-06 |
Merck Sharp & Dohme Llc |
2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
|
|
CN115697327A
(zh)
|
2020-06-17 |
2023-02-03 |
默沙东有限责任公司 |
作为nav1.8抑制剂的5-氧代-吡咯烷-3-甲酰胺
|
|
EP4196482B1
(en)
|
2020-08-14 |
2025-10-01 |
SiteOne Therapeutics, Inc. |
Non-hydrated ketone inhibitors of nav1.7 for the treatment of pain
|
|
WO2022037647A1
(zh)
|
2020-08-19 |
2022-02-24 |
江苏恒瑞医药股份有限公司 |
一种选择性Nav抑制剂的结晶形式及其制备方法
|
|
TW202214259A
(zh)
|
2020-08-19 |
2022-04-16 |
大陸商江蘇恆瑞醫藥股份有限公司 |
一種選擇性ＮａＶ抑制劑的前藥及其晶型
|
|
CN111808019B
(zh)
|
2020-09-08 |
2020-11-27 |
上海济煜医药科技有限公司 |
一种并环化合物及其应用
|
|
CN112225695B
(zh)
|
2020-12-15 |
2021-03-02 |
上海济煜医药科技有限公司 |
一种氮氧化合物及其制备方法和用途
|
|
CN112457294B
(zh)
|
2021-01-27 |
2021-06-04 |
上海济煜医药科技有限公司 |
一种作为NaV1.8阻滞剂的化合物及其制备方法和用途
|
|
AU2022283934A1
(en)
*
|
2021-06-04 |
2023-11-30 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channels
|